Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)

This study has been completed.
Sponsor:
Collaborator:
Clinical Research Center for Solid Tumor, Korea
Information provided by (Responsible Party):
Dae Seog Heo, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT00623558
First received: February 17, 2008
Last updated: December 3, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)